-
CSCO International Vision | Professors Zefei Jiang and Giuseppe Curigliano: CSCO x ESMO Join Forces to Build a United Front Against Cancer, Setting a Milestone with DB09 in HER2-Targeted Therapy
The 28th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) was held in Jinan, Shandong, from September 10 to 14, 2025, under the theme “Standardized Treatment, Innovation-Driven Progress.” The meeting gathered leading scholars from China and abroad for a major exchange of ideas. In the field of breast cancer, Professor Giuseppe Curigliano, President-Elect…
-
2025 COMB丨Professor Fei Ma: New Perspectives in Breast Cancer Immunotherapy—Mechanistic Insights, Adverse Event Management, and Precision Pathways
Synergistic Mechanisms of Metronomic Chemotherapy with Immunotherapy Oncology Frontier:Your team’s phase II prospective randomized study suggested significant differences in synergy between immunotherapy and various chemotherapy regimens. Mechanistically, how does metronomic…
-
EBMT President-Elect Professor Ibrahim Yakoub-Agha: Allogeneic Hematopoietic Stem Cell Transplantation for Myeloproliferative Neoplasms
Part 1 Oncology Frontier – Hematology Frontier: In current clinical practice, where JAK inhibitors are often used as a bridge to transplantation, how do you determine the optimal timing for…
-
2025 COMB丨Professor Jiayu Wang: Balancing Individualized Treatment and Liver Function Preservation in Breast Cancer Liver Metastases
Epidemiology of Breast Cancer Liver Metastases Oncology Frontier: Liver metastasis is one of the most common sites of distant spread in breast cancer and a major therapeutic challenge. Could you…
Connecting Medical Expertise through Media